Business Responsibility and Sustainability Report for FY 2025-26 is enclosed.

August 28, 2026 BSE Limited National Stock Exchange of India Limited The Listing Department The Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1, G Block, 25th Floor, Dalal Street Bandra Kurla Complex Fort, Mumbai 400 001 Bandra (East), Mumbai 400051 Maharashtra, India Maharashtra, India BSE Scrip Code: 544309 NSE Symbol: IKS Dear Sir/Ma’am, Sub: Business Responsibility Sustainability Report (“BRSR”) for FY 2025-26. Pursuant to Regulation 34(2)(f) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the BRSR for financial year 2025- 26, along with Independent Assurance Statement on BRSR provided by KPB & Associates, Chartered Accountants, which also forms part of the Annual Report for FY 2025-26. The BRSR for the FY 2025-26 along with Independent Assurance Statement is available on the Company's website at the link: https://ikshealth.com/investor-relations/ We request you to take the same on your records Yours sincerely, For Inventurus Knowledge Solutions Limited Sameer Chavan Company Secretary and Compliance Officer Membership No. F7211 Encl: As above Inventurus Knowledge Solutions Limited Registered Address: 801, Building No. 5, 8th Floor, Mindspace Business Park (SEZ), Thane-Belapur Road, Airoli, Navi Mumbai – 400708, Thane, Maharashtra, India Ph.: +91 22 3071 1100 | W: www.ikshealth.com | CIN: L72200MH2006PLC337651 Corporate Overview Statutory Reports Financial Statements BUSINESS RESPONSIBILITY & SUSTAINABILITY REPORT 2025-2026 SECTION A: GENERAL DISCLOSURES I. Details of the listed entity: Particulars Details 1 Corporate Identity Number (CIN) of the Listed L72200MH2006PLC337651 Entity 2 Name of the Listed Entity Inventurus Knowledge Solutions Limited (“The Company/IKS Health/ We/ Our”) 3 Year of incorporation 2006 4 Registered office address 801, Building No. 5&6, 8th Floor, Mindspace Business Park (SEZ), Thane-Belapur Road, Airoli, Navi Mumbai – 400708, Maharashtra, India. 5 Corporate address 801, Building No. 5&6, 8th Floor, Mindspace Business Park (SEZ), Thane-Belapur Road, Airoli, Navi Mumbai – 400708, Maharashtra, India. 6 E-mail investor_relations@ikshealth.com 7 Telephone +91 22 3964 3205 8 Website https://ikshealth.com/ 9 Financial year for which reporting is being April 1, 2025 - March 31, 2026 done 10 Name of the Stock Exchange(s) where shares National Stock Exchange of India Limited (NSE) are listed BSE Limited 11 Paid-up Capital 171,573,159 12 Name and contact details (telephone, Saransh Mundra email address) of the person who may be Contact - +91 22 39643205 contacted in case of any queries on the BRSR investor_relations@ikshealth.com report 13 Reporting boundary: Are the disclosures Disclosures made in this report are on a standalone basis. under this report made on a standalone basis (i.e. only for the entity) or on a consolidated basis (i.e. for the entity and all the entities which form a part of its consolidated financial statements, taken together). 14 Name of assurance provider KPB & Associates 15 Type of assurance obtained Reasonable Assurance of BRSR Core Indicators (ISAE 3000) II. P roducts/services 16. Details of business activities (accounting for 90% of the turnover): Sr. % of Turnover of Description of Main Activity Description of Business Activity No. the Entity 1. Other professional, scientific IKS Health is on a mission to enable the efficient delivery of 100% and technical activities high-quality care through a combination of leading-edge technology and human expertise. The IKS Care Enablement Platform enables us to deliver the chores of healthcare across administrative, clinical, and operational burdens, to enable clinicians to focus on their core purpose: delivering great care and bringing joy and purpose back to medicine. We are redefining the future of Care Enablement and creating transformative value in healthcare by empowering clinicians to build healthier communities and enabling stronger, financially sustainable enterprises. Our global team of 13,331, including 550 technologists and 1,981 clinical staff, enables clinicians to revitalize the clinician and patient experience. Annual Report 2025-26 17. Products/Services sold by the entity (accounting for 90% of the entity’s Turnover): Sr. % of Turnover Contributed by Product/Services NIC Code No the Product/Service 1. Other information technology and computer service activities 629099 100% III. O perations 18. Number of locations where plants and/or operations/offices of the entity are situated: Locations No. of Plants No. of Offices Total 1 National - 3 3 2 International - - - 19. Markets served by the entity: a. Number of locations Locations Number 1 National (No. of States) 0 2 International (No. of Countries) 1 b. W hat is the contribution of exports as a percentage of the total turnover of the entity? T he Company is a technology-enabled healthcare solutions provider, offering its Care Enablement Platform and associated services predominantly to healthcare enterprises located in the United States, with a presence in Canada and Australia as well. Accordingly, a substantial portion of the Company’s revenue is derived from exports of services from India. D uring the financial year under review, exports contributed approximately 100% of the Company’s total turnover. c. A brief on types of customers I KS Health delivers healthcare technology, clinical support, and care enablement solutions to a broad range of clients, including large hospitals, integrated health systems, speciality physician groups, and other healthcare organisations across the United States. IV. Employees 20. Details as of March 31, 2026 a. Employees and workers (including differently abled): Male Female No Type Total (A) No. of Males % of Males No. of Females % of Females (B) (B/A) (C) (C/A) Employees 1 Permanent (D) 9,698 5,641 58.17% 4,057 41.83% 2 Other than Permanent (E) 62 37 59.68% 25 40.32% 3 Total Employees (D + E) 9,760 5,678 58.18% 4,082 41.82% Note: IKS Health does not have any workers. b. Differently abled employees and workers: Male Female No Type Total (A) No. of Males % of Males No. of % of Females (B) (B/A) Females (C) (C/A) Differently- abled Employees 1 Permanent (D) - - - - - 2 Other than Permanent (E) - - - - - 3 Total Employees (D + E) - - - - - Note: IKS Health does not have any differently abled employees. Corporate Overview Statutory Reports Financial Statements 21. P articipation/Inclusion/Representation of women Particulars Total (A) No. of Females (B) % of Females (B/A) 1 Board of Directors 11 3 27% 2 Key Management Personnel 2 1 50% 22. T urnover rate for permanent employees and workers FY 2023-24 FY 2025-26 FY 2024-25 Particulars (Turnover rate in the year prior (Turnover rate in current FY) (Turnover rate in previous FY) to the previous FY) Category Male Female Total Male Female Total Male Female Total Permanent Employees 36.2% 39% 37.41% 48.4% 53.3% 50.77% 54.2% 57.5% 55.83% Permanent Workers Not Applicable Note: The company does not have any permanent workers. V. Holding, Subsidiary and Associate Companies (including joint ventures) 23. (a) N ames of holding/subsidiary / associate companies / joint ventures (As on March 31, 2026) Does the entity indicated Indicate whether Holding/ at column A, participate in Sr. Name of the holding/subsidiary / % of shares held Subsidiary/ Associate / the Business Responsibility No associate companies / joint ventures (A) by listed entity Joint Venture Initiatives of the listed entity? (Yes/No) 1 Inventurus Knowledge Solutions Inc Subsidiary 100% No 2 IKS Cares Foundation Subsidiary 100% No 3 Aquity Holdings Inc* Subsidiary 100% (Indirect) No 4 Aquity Solutions LLC* Subsidiary 100% (Indirect) No 5 Aquity Solutions India Private Limited* Subsidiary 100% (Indirect) No 6 Aquity Solutions Australia Pty Limited* Subsidiary 100% (Indirect) No 7 Aquity Canada ULC * Subsidiary 100% (Indirect) No 8 IKS Next Horizon, Inc* [Showing first 8,000 characters — download PDF for full document]